sábado, 22 de julio de 2017

Antimicrobial Resistance Spotlight - Emerging Infectious Disease journal - CDC

Antimicrobial Resistance Spotlight - Emerging Infectious Disease journal - CDC

CDC - Centers for Disease Control and Prevention - CDC 24/7: Saving Lives. Protecting People.™

EMERGING INFECTIOUS DISEASES®



Antimicrobial Resistance

Antibiotics and similar drugs, together called antimicrobial agents, have been used for the last 70 years to treat people who have infectious diseases. Since the 1940s, these drugs have greatly reduced illness and death from infectious diseases. However, these drugs have been used so widely and for so long that the infectious organisms the antibiotics are designed to kill are adapting to them, making the drugs less effective.
Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections.

Articles

Rapid Detection of Polymyxin Resistance in Enterobacteriaceae
P. Nordmann et al. (2017 Volume 23, Number 6)
Shigella Antimicrobial Drug Resistance Mechanisms, 2004–2014
M. Nüesch-Inderbinen et al. (2017 Volume 23, Number 6)
Rapid Detection of Polymyxin Resistance in Enterobacteriaceae
Patrice Nordmann et al. (2016 Volume 22, Number 6)
Shigella Antimicrobial Drug Resistance Mechanisms, 2004–2014
Magdalena Nüesch-Inderbinen et al. (2016 Volume 22, Number 6)
Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina
Ricardo Gianecini et al. (2016 Volume 22, Number 6)
Microbial Biofilms, Second Edition
Rodney M. Donlan (2016 Volume 22, Number 6)
Determinants and Drivers of Infectious Disease Threat Events in Europe
J. C. Semenza et al. (2016 Volume 22, Number 4)
Medscape CME Activity
Shiga Toxin 1–Producing Shigella sonnei Infections, California, United States, 2014–2015
K. Lamba et al. (2016 Volume 22, Number 4)
Depictions of Heroism in Battle and Anguish from Tuberculosis
T. L. Chorba and B. Breedlove (2016 Volume 22, Number 3)
Importation of Fosfomycin Resistance fosA3 Gene to Europe
A. C. Mendes et al. (2016 Volume 22, Number 2)
CTX-M-15–Producing Escherichia coli in Dolphin, Portugal
V. Manageiro et al. (2015 Volume 21, Number 12)
Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
H. Alrowais et al. (2015 Volume 21, Number 11)
Emerging Infections Program—State Health Department Perspective
J. L. Hadler et al. (2015 Volume 21, Number 9)

Podcasts

Other Resources

No hay comentarios:

Publicar un comentario